July 9, 2019

Procyrion Raises $30 Million Series D to Support Clinical Trials of its Aortix™ Percutaneous Blood Pump for Treating Heart Failure Patients

The $30M Series D funding, led by a new investor, Bluebird Ventures, will support the Aortix's pilot study through the submission of an FDA IDE application for its pivotal trial.

Read More
Older Posts